111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YI) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 9,363 shares, an increase of 107.5% from the June 30th total of 4,513 shares. Based on an average daily volume of 17,270 shares, the short-interest ratio is presently 0.5 days. Currently, 0.2% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 2nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Insiders Place Their Bets

In other 111 news, Director Jian David Sun sold 115,440 shares of the firm’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $0.22, for a total value of $25,396.80. Following the completion of the sale, the director directly owned 583,111 shares of the company’s stock, valued at $128,284.42. This trade represents a 16.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 595,540 shares of company stock worth $141,105 over the last three months. 43.90% of the stock is currently owned by corporate insiders.

111 Stock Down 9.9%

YI opened at $3.56 on Thursday. The firm has a 50-day moving average price of $4.38 and a 200-day moving average price of $5.81. 111 has a twelve month low of $2.48 and a twelve month high of $11.17. The company has a market capitalization of $31.29 million, a price-to-earnings ratio of -2.54 and a beta of 0.63.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.